Lipella Pharmaceuticals Inc (LIPO)
NASDAQ
Quarter End | Mar 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |||||
Total Revenue | 33k | 118k | 107k | 104k | 121k | 146k | 136k | 81k |
Operating Income | -736k | -1.09M | -1.57M | -1.36M | -730k | -1.22M | -952k | -1.46M |
Pre Tax Income | -738k | -1.07M | -1.54M | -1.32M | -689k | -1.19M | -938k | -1.44M |
Net Income | -738k | -1.07M | -1.54M | -1.32M | -689k | -1.19M | -938k | -1.44M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -737k | -1.09M | -1.57M | -1.36M | -730k | -1.22M | -952k | -1.46M |
EBITDA | -736k | -1.09M | -1.57M | -1.36M | -729k | -1.22M | -951k | -1.46M |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 962k | 259k | 184k | 450k |
Operating Income | -57k | -1.92M | -2.59M | -4.75M |
Pre Tax Income | -62k | -1.87M | -2.6M | -4.62M |
Net Income | -62k | -1.87M | -2.6M | -4.62M |
Preferred Dividends | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -0.011 | -0.193 | -0.269 | -0.796 |
EBIT | -57k | -1.86M | -2.59M | -4.75M |
EBITDA | -57k | -1.92M | -2.59M | -4.74M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.